These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31348550)

  • 1. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
    Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations.
    Blumenfeld Z; Koop MM; Prieto TE; Shreve LA; Velisar A; Quinn EJ; Trager MH; Brontë-Stewart H
    Mov Disord; 2017 Jan; 32(1):80-88. PubMed ID: 27859579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
    Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
    López-Azcárate J; Tainta M; Rodríguez-Oroz MC; Valencia M; González R; Guridi J; Iriarte J; Obeso JA; Artieda J; Alegre M
    J Neurosci; 2010 May; 30(19):6667-77. PubMed ID: 20463229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
    Gulberti A; Schneider TR; Galindo-Leon EE; Heise M; Pino A; Westphal M; Hamel W; Buhmann C; Zittel S; Gerloff C; Pötter-Nerger M; Engel AK; Moll CKE
    Neurobiol Dis; 2024 Jul; 197():106529. PubMed ID: 38740349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication.
    Tinkhauser G; Pogosyan A; Tan H; Herz DM; Kühn AA; Brown P
    Brain; 2017 Nov; 140(11):2968-2981. PubMed ID: 29053865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Responses to Low- and High-Frequency Subthalamic Nucleus Deep Brain Stimulation on Sensor-Measured Components of Bradykinesia in Parkinson's Disease.
    Mishra A; Bajaj V; Fitzpatrick T; Watts J; Khojandi A; Ramdhani RA
    Sensors (Basel); 2024 Jul; 24(13):. PubMed ID: 39001075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson's Disease.
    Momin S; Mahlknecht P; Georgiev D; Foltynie T; Zrinzo L; Hariz M; Zacharia A; Limousin P
    J Parkinsons Dis; 2018; 8(2):267-271. PubMed ID: 29614696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.
    Kühn AA; Kupsch A; Schneider GH; Brown P
    Eur J Neurosci; 2006 Apr; 23(7):1956-60. PubMed ID: 16623853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-frequency coupling between gamma oscillations and deep brain stimulation frequency in Parkinson's disease.
    Muthuraman M; Bange M; Koirala N; Ciolac D; Pintea B; Glaser M; Tinkhauser G; Brown P; Deuschl G; Groppa S
    Brain; 2020 Dec; 143(11):3393-3407. PubMed ID: 33150359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
    Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
    Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.